NextCure to Present at Morgan Stanley Virtual 18th Annual Global Healthcare ConferenceGlobeNewsWire • 09/08/20
NextCure Provides an Interim Update of the Phase 2 Portion of the NC318 Monotherapy Phase 1/2 Trial and Announces Departure of Chief Medical OfficerGlobeNewsWire • 07/13/20
NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid TumorsGlobeNewsWire • 07/07/20
NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual MeetingGlobeNewsWire • 05/29/20
NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 PandemicGlobeNewsWire • 04/13/20
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of DirectorsGlobeNewsWire • 03/30/20
NextCure's Big Rise And Fall, And Other Headlines: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 11/13/19
Analyst Trims NextCure Price Target Following SITC Presentation, Still Sees Big UpsideBenzinga • 11/12/19